Calidi Biotherapeutics, Inc. (CLDI)

Operating Cash Flow Growth

20.68%

TTM · Period ending:

CLDI logo

CLDI Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported20.68%
CLDI TTM Cash from Operations YoY % (-123.77% → 20.68%)
High-resolution chart · PNG

CLDI operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Calidi Biotherapeutics, Inc. Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
20.6837%
14.3125%
-18.0911%
-21.7939%
15.1147%
23.0122%
33.1764%
30.6898%
-26.9979%
-49.4107%
-53.809%
-56.4264%
-123.7685%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.